Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: SADIF-Investment Analytics, S.A.
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

RNL BIO Co., Ltd. Announces Amendments to Merge with RNL SAMMI CO.,LTD.


Tuesday, 19 Feb 2013 03:25am EST 

RNL BIO Co., Ltd. announced that it has made amendments to the merger with RNL SAMMI CO.,LTD., initially announced on May 12, 2011. After the amendments, the expected merger effective date has been amended to July 16, 2013 and 4,503,647 common shares will be issued with the merger. 

Company Quote

1665.0
-65.0 -3.76%
11 Jul 2014